Gene · 7130
Papers2,523
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 2,523
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| TSG-6 Is Involved in Fibrous Structural Remodeling after the Injection of Adipose-derived Stem Cells. | Plast Reconstr Surg Glob Open | 2024 | 39036595 | PubTator, text mining | PubMed |
| Adipose-derived mesenchymal stromal cells alleviate intestinal fibrosis: The role of tumor necrosis factor-stimulated gene 6 protein. | Int Immunopharmacol | 2024 | 39024752 | PubTator, text mining | PubMed |
| TSG-6+ cancer-associated fibroblasts modulate myeloid cell responses and impair anti-tumor response to immune checkpoint therapy in pancreatic cancer. | Nat Commun | 2024 | 38987547 | PubTator, text mining | PubMed |
| The complex association between the immune system and the skeletal system in osteoporosis: A study of single-cell RNA sequencing. | Int Immunopharmacol | 2024 | 38976947 | PubTator, text mining | PubMed |
| Transcriptional markers classifying Escherichia coli and Staphylococcus aureus induced sepsis in adults: A data-driven approach. | PLoS One | 2024 | 38968271 | PubTator, text mining | PubMed |
| Identification of TNFAIP6 as a reliable prognostic indicator of low-grade glioma. | Heliyon | 2024 | 38948040 | PubTator, text mining | PubMed |
| Alexander Friedenstein, Mesenchymal Stem Cells, Shifting Paradigms and Euphemisms. | Bioengineering (Basel) | 2024 | 38927770 | PubTator, text mining | PubMed |
| Applications of Stem Cell-Derived Extracellular Vesicles in Nerve Regeneration. | Int J Mol Sci | 2024 | 38892052 | PubTator, text mining | PubMed |
| TFAIP6 facilitates hepatocellular carcinoma cell glycolysis through upregulating c-myc/PKM2 axis. | Heliyon | 2024 | 38813227 | PubTator, text mining | PubMed |
| TGF-β1 induces formation of TSG-6-enriched extracellular vesicles in fibroblasts which can prevent myofibroblast transformation by modulating Erk1/2 phosphorylation. | Sci Rep | 2024 | 38811625 | PubTator, text mining | PubMed |
| Human mesenchymal stromal cells ameliorate cisplatin-induced acute and chronic kidney injury via TSG-6. | Stem Cells | 2024 | 38804841 | PubTator, text mining | PubMed |
| Research advances in Zein-based nano-delivery systems. | Front Nutr | 2024 | 38798768 | PubTator, text mining | PubMed |
| Tumor necrosis factor-inducible gene 6 protein and its derived peptide ameliorate liver fibrosis by repressing CD44 activation in mice with alcohol-related liver disease. | J Biomed Sci | 2024 | 38790021 | PubTator, text mining | PubMed |
| Exploring the Role of Extracellular Vesicles in the Pathogenesis of Tuberculosis. | Genes (Basel) | 2024 | 38674369 | PubTator, text mining | PubMed |
| hUC-MSCs therapy for Crohn's disease: efficacy in TNBS-induced colitis in rats and pilot clinical study. | EBioMedicine | 2024 | 38653187 | PubTator, text mining | PubMed |
| Enhanced potent immunosuppression of intracellular adipose tissue-derived stem cell extract by priming with three-dimensional spheroid formation. | Sci Rep | 2024 | 38643332 | PubTator, text mining | PubMed |
| Immunomodulatory Effect of Phytoactive Compounds on Human Health: A Narrative Review Integrated with Bioinformatics Approach. | Curr Top Med Chem | 2024 | 38551050 | PubTator, text mining | PubMed |
| An Overview of Mesenchymal Stem Cell Heterogeneity and Concentration. | Pharmaceuticals (Basel) | 2024 | 38543135 | PubTator, text mining | PubMed |
| Extracellular Vesicles: A Crucial Player in the Intestinal Microenvironment and Beyond. | Int J Mol Sci | 2024 | 38542448 | PubTator, text mining | PubMed |
| TSG-6 Inhibits the NF-κB Signaling Pathway and Promotes the Odontogenic Differentiation of Dental Pulp Stem Cells via CD44 in an Inflammatory Environment. | Biomolecules | 2024 | 38540786 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7130/papers?page=8